Matches in Wikidata for { <http://www.wikidata.org/entity/Q64715630> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q64715630 description "clinical trial" @default.
- Q64715630 description "ensayu clínicu" @default.
- Q64715630 description "klinisch onderzoek" @default.
- Q64715630 description "клінічне випробування" @default.
- Q64715630 name "Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset Seizures" @default.
- Q64715630 type Item @default.
- Q64715630 label "Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset Seizures" @default.
- Q64715630 prefLabel "Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset Seizures" @default.
- Q64715630 P1050 Q64715630-D2FD35C8-BF51-45B0-8B8F-E4E98D4DDA8A @default.
- Q64715630 P1132 Q64715630-CD5D8ABE-C46A-4AB4-8B40-9A2ABBEF301F @default.
- Q64715630 P1476 Q64715630-50FAB71F-86E7-4EB7-91AD-C5B72034EC39 @default.
- Q64715630 P17 Q64715630-66519E3B-909F-4109-B5F7-88099A05A2F5 @default.
- Q64715630 P17 Q64715630-6B22A075-61A6-482C-A2E6-13E033A389BF @default.
- Q64715630 P17 Q64715630-7F199850-62E5-49B3-8E5C-6B242300E517 @default.
- Q64715630 P17 Q64715630-EBC55C24-FA80-47AE-B00D-0C79B6818FE3 @default.
- Q64715630 P17 Q64715630-F0616E82-587D-456F-8EE3-8B1DBCE8D80A @default.
- Q64715630 P1813 Q64715630-7063C307-CAF2-48FF-AC86-8936F22C7691 @default.
- Q64715630 P2899 Q64715630-FC0ECF59-4EB5-4729-AAD0-9B96433AA223 @default.
- Q64715630 P3098 Q64715630-926CE419-9DD0-4ECD-A63B-5006739A1003 @default.
- Q64715630 P31 Q64715630-077D16EE-7434-44AD-B60B-E44D3C9F4387 @default.
- Q64715630 P580 Q64715630-AEC6A0BF-4A41-4802-9ACC-92CBED53968B @default.
- Q64715630 P582 Q64715630-66A3272B-EE1D-4BF4-8666-B1E1BFD00477 @default.
- Q64715630 P8363 Q64715630-A8038365-FAE5-4D7B-8726-5552910003CC @default.
- Q64715630 P921 Q64715630-488DFE5B-3571-487D-B54F-D4824544AA2F @default.
- Q64715630 P921 Q64715630-618A8ED4-E52E-4B36-ACB9-4AFD73AFB57B @default.
- Q64715630 P921 Q64715630-AE60D58D-56FD-44AF-833F-3DA0C7202233 @default.
- Q64715630 P1050 Q41571 @default.
- Q64715630 P1132 "+1005" @default.
- Q64715630 P1476 "Post-Authorization Safety Study to Evaluate the Long-Term Safety and Tolerability of Vimpat® (Lacosamide) as Add-On Therapy in Epilepsy Patients With Partial-Onset Seizures Who Are Uncontrolled on Current Therapy" @default.
- Q64715630 P17 Q142 @default.
- Q64715630 P17 Q145 @default.
- Q64715630 P17 Q183 @default.
- Q64715630 P17 Q29 @default.
- Q64715630 P17 Q55 @default.
- Q64715630 P1813 "PASS" @default.
- Q64715630 P2899 "+16" @default.
- Q64715630 P3098 "NCT00771927" @default.
- Q64715630 P31 Q30612 @default.
- Q64715630 P580 "2008-10-01T00:00:00Z" @default.
- Q64715630 P582 "2012-03-01T00:00:00Z" @default.
- Q64715630 P8363 Q818574 @default.
- Q64715630 P921 Q18967838 @default.
- Q64715630 P921 Q59423364 @default.
- Q64715630 P921 Q7140388 @default.